Symbol | Exchange | Currency |
|---|
Evgen Pharma plc is a United Kingdom-based clinical-stage drug development company. The Company is focused on the clinical development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. Its Sulforadex technology enables sulforaphane to be delivered as a stable, solid, active ingredient in an oral pharmaceutical product. Its lead drug, SFX-01, exploits sulforaphane’s activity in three separate biochemical pathways, such as inhibition of STAT3 and SHP2, of importance in controlling cancers metastases, and up-regulation of Nrf2, a pathway of significance in several different diseases. The Company pipeline includes SFX-01 and breast cancer, SFX-01 and glioma, and SFX-01 and SHP2. SFX-01 for the treatment of metastatic breast cancer and acute respiratory distress syndrome. The Company is also researching a range of synthetic, stabilized novel analogues of sulforaphane to advance the pharmaceuticals.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 10.25 | 10.25 | 10.25 | 0.00 | 0.00% | 0.00 | London | |||
| 604.10 | 606.20 | 601.00 | +8.10 | +1.36% | 5.88M | London | |||
| 509.68 | 513.10 | 488.20 | +31.33 | +6.55% | 19.27M | London | |||
| 107.64 | 108.60 | 107.14 | -0.44 | -0.41% | 43.66M | London | |||
| 3.739 | 3.739 | 3.739 | -0.0500 | -1.32% | 128.59K | London | |||
| 8.696 | 9.30 | 8.30 | +0.396 | +4.77% | 48.15M | London | |||
| 79.00 | 81.00 | 79.00 | -1.40 | -1.74% | 186.24K | London | |||
| 4.96 | 5.06 | 4.83 | 0.00 | 0.00% | 0.00 | London | |||
| 212.50 | 213.00 | 212.50 | 0.00 | 0.00% | 0.00 | London | |||
| 421.75 | 425.00 | 420.50 | -0.25 | -0.06% | 436.25K | London | |||
| 4.29 | 4.70 | 4.08 | +0.09 | +2.14% | 16.17M | London | |||
| 492.62 | 498.50 | 492.50 | -3.00 | -0.60% | 96.65K | London | |||
| 51.09 | 52.40 | 51.00 | +0.09 | +0.18% | 600.13K | London | |||
| 3.09 | 3.08 | 3.08 | -0.10 | -3.17% | 1.10M | London | |||
| 209.37 | 212.71 | 208.80 | -3.03 | -1.43% | 409.26K | London |